NDC 51759-710 – Ustekinumab-aekn
Ustekinumab-aekn 90 mg/mL · Injection, Solution · Subcutaneous
Product NDC51759-710
Product details
- Brand name
- Ustekinumab-aekn
- Generic name
- Ustekinumab-aekn
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761343
- Marketed since
- June 2, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interleukin-12 Antagonist; Interleukin-23 Antagonist
Active ingredients
- Ustekinumab-aekn 90 mg/mL
Uses, dosage, side effects and warnings for Ustekinumab-aekn →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 51759-710-32 | 1 TRAY in 1 CARTON (51759-710-32) / 1 SYRINGE, GLASS in 1 TRAY / 1 mL in 1 SYRINGE, GLASS | Jun 2, 2025 |